Financial Network Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Financial Network Wealth Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13	Closed	-$1.11K	–	825
2025 Q4	$1.11K	Hold	13	–	–	﹤0.01%	772
2025 Q3	$1.01K	Hold	13	–	–	﹤0.01%	783
2025 Q2	$1.02K	Buy	+13	New	+$970	﹤0.01%	768
2024 Q3	–	Sell	-2	Closed	-$185	–	860
2024 Q2	$185	Buy	+2	New	+$177	﹤0.01%	920

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Financial Network Wealth Advisors's EW Position: Q1 2026 in Review

Financial Network Wealth Advisors sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 13 shares — an estimated $1.11K sold.

Financial Network Wealth Advisors first reported a position in EW in Q2 2024 and held it in 4 quarters. The position peaked at $1.11K in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Financial Network Wealth Advisors reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
Financial Network Wealth Advisors sold 13 Edwards Lifesciences shares in Q1 2026, an estimated $1.11K.
Financial Network Wealth Advisors first reported a position in Edwards Lifesciences in Q2 2024 and held it in 4 quarters.
Financial Network Wealth Advisors's Edwards Lifesciences position peaked at $1.11K in Q4 2025.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.